C50
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - written consent after verbal clarification by an Study physician for this study is available - Histologically proven invasive breast cancer - Non-palpable tumor - Indication for BEI - CT1b-cT2 - Female patient> 18 years - Sonographically detectable tumor in two levels - Karnofsky Performance Status - Index =70% or ECOG <2
Exclusion criteria
Exclusion criteria: - Multifocal tumor - Recurrence of breast cancer - Tumor <5mm - Inability to understand the meaning and purpose of the clinical trial or the comply with conditions for studying OP capability not available
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of R0 resections, ie the rate of histologically safe in healthy distant breast cancer, with a safety margin of 1mm, at BEI after wire localization vs. BEI after intraoperative US, with the objective of demonstrating non-inferiority of the intraoperative ultrasound with respect to the wire marking. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary study objectives: - Comparison of the rate of intraoperative resections under two localization methods - Comparison of the rate of second operations under both localization methods - Comparison of the remote resection volume in both arms - Cosmetic Results - Operation time - Determining an optimum ultrasound distance between the tumor and the resection margin in order to achieve a minimal histological safety margin of 1mm - Evaluation of the measured tumor size in breast ultrasound, mammography and possibly in MR mammography compared to pathologically measured tumor size - Determination of characteristics of tumor biology, which are associated with an extensive intraductal component. | — |
Countries
Germany
Contacts
Universitätsfrauenklinik